Stay updated with breaking news from Markus Mayer. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Analyst Markus Mayer from Baader Bank research considers the stock attractive and recommends it with a Buy rating. The target price continues to be set at EUR 85. | February 25, 2022
Shares in Swiss chemicals group slump as much as 20% on news of delay and investigation
Business and Peace: Exploring the peacebuilding potential of medium, small and micro enterprises Format Exploring the peacebuilding potential of MSMEs On the occasion of the publication of the joint CDA / International Alert / FriEnt Dossier “Business and Peace: It takes Two to Tango” FriEnt invited about thirty experts from academia, German and international peace building and development Organisations to discuss and further develop central issues of the dossier. The first event in February 2021 was dedicated to the peace building potential of medium, small and micro enterprises (MSMEs)....
Trouble for the fertilizer group K + S (SDF) stock holders : The Federal Financial Supervisory Authority (Bafin) suspects that a billions in depreciation due to the drop in fertilizer prices may have been too low. The management of K + S is assuming that it will be able to invalidate the Bafin’s indications and has provided the relevant documents to the German Audit Office for Accounting (DPR). The shareholders reacted in shock, however, the share price collapsed in double digits. They fear further write-downs and possibly even a capital increase. The case concerns depreciation of two billi...
Bayer proposes paying $8 billion to settle Roundup cancer claims An agreement would ease investor pressure over massive litigation exposure the German drug and chemical giant took on with its $63 billion purchase of the weedkiller's maker, Monsanto. Written By: Washington Post | × The Bayer logo in Monheim, Germany, on March 21, 2018. Bloomberg photo by Jasper Juinen. Bayer is proposing to pay as much as $8 billion to settle more than 18,000 U.S. lawsuits alleging its Roundup herbicide causes cancer, according to people familiar with the negotiations. An agreement, which could...